ProtocolProtocolsFree

Body Recomposition Protocol

Peptides for fat loss and muscle preservation. Covers AOD-9604, Tesamorelin, and GH secretagogue strategies for metabolic optimization.

13 min read
Share:
By Peptides.NYC Editorial TeamUpdated May 21, 2026
Educational content only — not medically reviewed. Consult a licensed healthcare provider before acting on anything here.

Educational content only. Not medical advice. The content creators are not doctors or medical professionals. Consult your healthcare provider before taking any action.

Understanding Body Recomposition Peptides

Body recomposition—losing fat while preserving or building muscle—is the holy grail of physique optimization. While GLP-1 agonists dominate weight loss conversations, a separate category of peptides works through growth hormone pathways to enhance fat metabolism while supporting lean tissue.

This protocol covers the key peptides for body recomposition: AOD-9604, Tesamorelin, and growth hormone secretagogues. Each approach offers distinct advantages depending on your goals, health status, and access.


The Three Approaches

1. AOD-9604 (The Fat Loss Fragment)

A modified fragment of human growth hormone (amino acids 177-191) that stimulates lipolysis without the full effects of HGH.

Best for: Those wanting fat-specific effects without growth hormone's broader actions.

2. Tesamorelin (FDA-Approved GHRH)

A growth hormone-releasing hormone analog that stimulates your pituitary to release more natural GH.

Best for: Targeting visceral (belly) fat specifically; those who qualify for prescription.

3. GH Secretagogue Stacks (GHRP + GHRH)

Combinations of peptides that work synergistically to increase natural GH production.

Best for: Comprehensive body recomposition with anti-aging and recovery benefits.


AOD-9604 Protocol

What is AOD-9604?

AOD-9604 is a synthetic peptide consisting of a modified fragment of human growth hormone. It includes the lipolytic (fat-burning) region of HGH while omitting the portions responsible for IGF-1 stimulation and growth effects.

How It Works

  • Stimulates lipolysis (breakdown of stored fat)
  • Inhibits lipogenesis (formation of new fat)
  • Does not affect blood glucose or insulin
  • Does not stimulate IGF-1 production
  • Does not promote tissue growth

Dosing Protocol

Standard protocol:

  • Dose: 250-300 mcg per day
  • Timing: Once daily, ideally in the morning on an empty stomach
  • Duration: 12-20 weeks
  • Injection: Subcutaneous (abdomen preferred)

Timing considerations:

  • Inject fasted (at least 2-3 hours since eating)
  • Wait 20-30 minutes before eating after injection
  • Some split into 2 doses (morning and before bed) for enhanced effect

What to Expect

Weeks 1-4: Minimal visible changes; peptide establishing in system Weeks 4-8: Beginning fat loss, particularly around midsection Weeks 8-12: More noticeable changes in body composition Weeks 12-20: Continued progress; assess for protocol continuation

Realistic expectations:

  • Fat loss is gradual, not dramatic
  • Works best combined with caloric deficit and exercise
  • Targets stubborn fat areas more effectively
  • Does not suppress appetite (unlike GLP-1s)

AOD-9604 vs. Fragment 176-191

Both target the same region of HGH, but:

  • AOD-9604 is more stable
  • AOD-9604 has been through more clinical research
  • Both are functionally similar for fat loss purposes

Tesamorelin Protocol

What is Tesamorelin?

Tesamorelin (brand name Egrifta) is a synthetic analog of growth hormone-releasing hormone (GHRH). It's FDA-approved for reducing visceral adipose tissue in HIV patients with lipodystrophy, but is used off-label for body composition goals.

How It Works

  • Stimulates pituitary gland to release natural growth hormone
  • Increases IGF-1 levels
  • Specifically targets visceral (abdominal) fat
  • Preserves or increases lean body mass
  • Mimics natural pulsatile GH release

Dosing Protocol

Standard protocol:

  • Dose: 2 mg once daily
  • Timing: Evening or before bed (mimics natural GH release)
  • Duration: 12-26 weeks minimum for visceral fat reduction
  • Injection: Subcutaneous (abdomen)

Administration tips:

  • Inject at the same time each day
  • Fasted state improves GH response
  • Evening dosing aligns with natural GH secretion patterns

What to Expect

Weeks 1-4: Improved sleep quality, increased energy Weeks 4-12: Beginning reduction in waist circumference Weeks 12-26: Significant visceral fat reduction (studies show 15-18% reduction) Ongoing: Continued benefits with sustained use

Tesamorelin Considerations

Advantages:

  • FDA-approved with established safety data
  • Specifically effective for visceral fat
  • Preserves lean mass
  • Mimics natural physiology

Limitations:

  • Requires prescription
  • Relatively expensive
  • Must be used consistently for results
  • Effects reverse upon discontinuation

GH Secretagogue Stacks

The Synergy Concept

Growth hormone secretagogues work best in combinations that amplify natural GH release:

GHRH (Growth Hormone-Releasing Hormone) peptides:

  • Stimulate GH release from pituitary
  • Work best when somatostatin is low
  • Examples: CJC-1295, Sermorelin, Tesamorelin

GHRP (Growth Hormone-Releasing Peptides):

  • Stimulate GH release through ghrelin receptors
  • Suppress somatostatin (removes the brake)
  • Examples: GHRP-2, GHRP-6, Ipamorelin, Hexarelin

Combined effect: GHRP suppresses somatostatin while GHRH stimulates release = amplified GH pulse

Popular Stack: CJC-1295 + Ipamorelin

This combination is the most commonly used for body recomposition:

Why this combo:

  • Ipamorelin: Clean GH release with minimal cortisol/prolactin increase
  • CJC-1295 (no DAC): Amplifies GH pulse without extending duration excessively
  • Together: Synergistic GH release approximating natural pulsatility

Dosing protocol:

  • Ipamorelin: 200-300 mcg per injection
  • CJC-1295 (no DAC): 100-200 mcg per injection
  • Frequency: 2-3 times daily
  • Timing: Morning fasted, pre-workout, and before bed
  • Duration: 8-16 weeks, then reassess

Alternative Stacks

GHRP-2 + CJC-1295 (no DAC):

  • Stronger GH release than Ipamorelin
  • May increase hunger (ghrelin stimulation)
  • Slightly more cortisol/prolactin elevation
  • Good for those wanting more aggressive protocol

GHRP-6 + Sermorelin:

  • Significant hunger increase (can help underweight individuals)
  • Strong GH release
  • More pronounced side effects
  • Not ideal if appetite control is a concern

Ipamorelin + Sermorelin:

  • Gentler approach
  • Minimal side effects
  • Good for beginners or those sensitive to peptides
  • Moderate GH elevation

Optimizing GH Secretagogue Results

Timing matters:

  • Inject fasted (blood sugar suppresses GH release)
  • Wait 20-30 minutes before eating post-injection
  • Before bed dose aligns with natural GH peaks

Lifestyle factors:

  • Sleep quality directly impacts GH release
  • High-intensity exercise amplifies effects
  • Chronic stress (cortisol) blunts GH response
  • Blood sugar stability supports GH secretion

Comparing the Approaches

FactorAOD-9604TesamorelinGH Secretagogues
MechanismDirect lipolysisGHRH → GH releaseGHRP + GHRH → GH
IGF-1 increaseNoYesYes
Muscle preservationMinimalYesYes
Anti-aging benefitsNoSomeYes
Appetite effectsNoneNoneVaries by peptide
Injection frequency1x daily1x daily2-3x daily
ComplexitySimpleSimpleMore complex
AccessResearch peptidePrescriptionResearch peptides

Choosing Your Approach

Choose AOD-9604 if:

  • You want fat-specific effects only
  • You prefer simpler protocols
  • You don't want IGF-1 elevation
  • You're looking for targeted fat loss without broader effects

Choose Tesamorelin if:

  • Visceral fat is your primary concern
  • You can obtain a prescription
  • You want FDA-approved option with safety data
  • You value lean mass preservation

Choose GH Secretagogue stack if:

  • You want comprehensive body recomposition
  • Anti-aging and recovery benefits matter
  • You're comfortable with multiple daily injections
  • You want the synergy of elevated natural GH

Combining with GLP-1 Agonists

Some protocols combine GH-pathway peptides with GLP-1 agonists for enhanced results:

Potential benefits:

  • GLP-1 addresses appetite and caloric intake
  • GH peptides preserve muscle during weight loss
  • Different mechanisms may complement each other

Considerations:

  • More complexity and cost
  • Limited research on combinations
  • May be overkill for most goals
  • Start protocols separately to assess individual response

If combining:

  • Establish stable GLP-1 dose first
  • Add GH peptide after titration complete
  • Monitor for any unexpected interactions
  • Work with provider who understands both

Diet and Training Integration

Nutrition for Body Recomposition

Protein priority:

  • 0.8-1.2g per pound of goal body weight
  • Essential for muscle preservation during fat loss
  • Distribute across 4-5 meals

Caloric approach:

  • Moderate deficit (15-20% below maintenance)
  • Aggressive deficits compromise muscle retention
  • Cycling between deficit and maintenance may help

Meal timing:

  • Fasted state for peptide injections
  • Post-workout nutrition supports muscle protein synthesis
  • Evening carbs may support GH release during sleep

Training for Body Recomposition

Resistance training (essential):

  • 3-5 sessions per week
  • Progressive overload focus
  • Compound movements prioritized
  • Signal to body that muscle is needed

Cardiovascular exercise:

  • Moderate steady-state or HIIT
  • Don't overdo it (excessive cardio is catabolic)
  • 150-200 minutes weekly is sufficient

Recovery:

  • Sleep 7-9 hours (GH release happens during deep sleep)
  • Manage stress (cortisol antagonizes GH)
  • Don't overtrain

Monitoring Progress

What to Track

Body composition metrics:

  • Scale weight (context-dependent)
  • Waist circumference (especially for visceral fat)
  • Progress photos (consistent lighting/timing)
  • Body fat percentage if available
  • How clothes fit

Performance metrics:

  • Strength in key lifts
  • Recovery between sessions
  • Energy levels
  • Sleep quality

Bloodwork Monitoring

Baseline and periodic testing:

  • Fasting glucose and HbA1c
  • IGF-1 levels (for GH peptides)
  • Lipid panel
  • Liver enzymes
  • Thyroid panel

Frequency:

  • Baseline before starting
  • 8-12 weeks into protocol
  • Every 12-16 weeks ongoing

Frequently Asked Questions

How long before I see results with these peptides? Body recomposition is gradual. Expect 8-12 weeks minimum for noticeable changes. GH secretagogues may show recovery and sleep benefits earlier.

Can I use these peptides without diet and exercise? Results will be minimal. These peptides enhance the body's fat-burning processes but don't overcome caloric surplus or sedentary lifestyle.

Are these peptides better than GLP-1 agonists for fat loss? Different mechanisms, different results. GLP-1s typically produce more dramatic weight loss. GH-pathway peptides offer better muscle preservation and additional benefits but slower fat loss.

Can women use these protocols? Yes. The protocols work similarly for women. Dosing may be adjusted based on body weight.

Will these peptides affect my hormone levels? GH secretagogues increase GH and IGF-1, which can have downstream effects. AOD-9604 has minimal hormonal impact. Monitoring bloodwork helps track changes.


The Bottom Line

Body recomposition peptides offer targeted approaches to fat loss while supporting lean tissue—a significant advantage over purely caloric restriction. Whether you choose the simplicity of AOD-9604, the FDA-approved approach of Tesamorelin, or the comprehensive benefits of GH secretagogue stacks, success requires integration with proper nutrition and training.

These peptides are tools that enhance your body's fat-burning capabilities—they don't replace the fundamentals of diet, exercise, and recovery. Used correctly within a comprehensive program, they can help achieve body composition goals that are difficult through lifestyle alone.

Not medically reviewed

This content is produced by the Peptides.NYC editorial team from published research. It has not been reviewed by a licensed clinician and is educational only — always consult your healthcare provider before starting, stopping, or adjusting any peptide protocol.

Written By

Editorial team. We cite published research; we are not licensed clinicians and content is not medically reviewed.

Peptide researchHealth writingEvidence synthesis

This article cites peer-reviewed research and medical literature. Click any reference to view the original source.

  1. 1

    Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A (2022) Tirzepatide Once Weekly for the Treatment of Obesity N Engl J Med.

    PMID: 35658024DOI: 10.1056/NEJMoa2206038View on PubMed
  2. 2

    Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF (2021) Once-Weekly Semaglutide in Adults with Overweight or Obesity N Engl J Med.

    PMID: 33567185DOI: 10.1056/NEJMoa2032183View on PubMed
  3. 3

    Jastreboff AM, Kaplan LM, Frias JP, Wu Q, Du Y, Gurbuz S, Coskun T, Haupt A, Milicevic Z, Hartman ML (2023) Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial N Engl J Med.

    PMID: 37366315DOI: 10.1056/NEJMoa2301972View on PubMed
  4. 4

    Nunn E, Jaiswal N, Gavin M, Uehara K, Stefkovich M, Drareni K, Calhoun R, Lee M, Holman CD, Baur JA, Seale P, Titchenell PM (2024) Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism Mol Metab.

    PMID: 38218536DOI: 10.1016/j.molmet.2024.101880View on PubMed

Medical Disclaimer

The information on this website is for educational purposes only and is not medical advice. The content creators are not doctors or medical professionals. This content should not be used to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare provider before starting any new supplement, medication, or health protocol. You assume all risks associated with using this information.